DLB Dolby Laboratories, Inc.
Patent Owners & Lessors · NYSE · SEC CIK 1308547 · Fiscal year ends 09/27
Financial factors as of 2026-09-25 (2026Q4), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q4*2026-09-25 | 2026Q32026-06-26 | 2026Q22026-03-27 | 2026Q12025-12-26 | 2025Q4*2025-09-26 | 2025Q32025-06-27 | 2025Q22025-03-28 | 2025Q12024-12-27 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $373.54M | $305.00M | $395.63M | $346.71M | $307.02M | $315.55M | $369.56M | $357.00M |
| Cost of revenue | $58.24M | $40.32M | $44.73M | $43.21M | $39.52M | $44.00M | $35.84M | $40.77M |
| Gross profit | $315.30M | $264.68M | $350.90M | $303.50M | $267.50M | $271.54M | $333.72M | $316.23M |
| R&D expense | $64.30M | $65.75M | $63.65M | $69.08M | $67.47M | $65.98M | $61.71M | $66.64M |
| SG&A expense | $79.81M | $75.58M | $75.95M | $70.24M | $73.72M | $72.31M | $70.42M | $70.09M |
| Operating income | $94.57M | $34.32M | $112.95M | $62.16M | $29.68M | $47.64M | $107.76M | $79.88M |
| Pretax income | $102.28M | $43.80M | $119.70M | $71.60M | $41.67M | $55.52M | $120.25M | $86.05M |
| Income tax | $21.05M | $14.59M | $24.25M | $17.92M | -$7.99M | $8.97M | $28.02M | $17.98M |
| Net income | $80.89M | $28.60M | $94.92M | $53.33M | $49.33M | $46.07M | $91.79M | $67.82M |
| EBITDA | $118.73M | $56.92M | $137.04M | $86.31M | $51.67M | $69.57M | $129.30M | $102.24M |
| EPS (basic) | — | 0.30 | 1.00 | 0.56 | — | 0.48 | 0.95 | 0.71 |
| EPS (diluted) | — | 0.30 | 0.99 | 0.55 | — | 0.48 | 0.94 | 0.70 |
| Dividends declared per share | 0.36 | 0.36 | 0.36 | 0.36 | 0.33 | 0.33 | 0.33 | 0.33 |
| Weighted avg. shares (diluted) | — | 94.52M | 95.52M | 96.52M | — | 96.90M | 97.47M | 97.15M |
| Balance sheet | ||||||||
| Cash & equivalents | $622.88M | $669.39M | $594.28M | $643.85M | $701.89M | $756.56M | $750.34M | $611.66M |
| Short-term investments | $500,000 | $652,000 | $460,000 | $739,000 | $703,000 | $763,000 | — | — |
| Receivables | $301.08M | $285.15M | $391.29M | $373.09M | $331.10M | $297.61M | $314.11M | $339.30M |
| Inventory | $28.45M | $30.77M | $31.93M | $31.26M | $30.42M | $32.41M | $34.59M | $31.83M |
| Current assets | $1.33B | $1.33B | $1.41B | $1.41B | $1.39B | $1.34B | $1.39B | $1.29B |
| PP&E, net | $457.35M | $459.12M | $461.84M | $466.72M | $470.61M | $478.48M | $472.66M | $476.11M |
| Goodwill | $529.06M | $528.34M | $529.67M | $530.30M | $529.90M | $528.82M | $525.02M | $520.42M |
| Intangibles | $389.41M | $382.43M | $389.71M | $364.02M | $397.06M | $408.15M | $412.06M | $421.24M |
| Total assets | $3.17B | $3.16B | $3.25B | $3.19B | $3.23B | $3.20B | $3.23B | $3.16B |
| Current liabilities | $417.81M | $416.33M | $474.61M | $443.51M | $437.79M | $388.79M | $457.49M | $441.88M |
| Total liabilities | $556.01M | $563.89M | $622.36M | $589.25M | $595.81M | $581.75M | $646.02M | $641.57M |
| Shareholders' equity | $2.60B | $2.58B | $2.62B | $2.59B | $2.62B | $2.60B | $2.57B | $2.51B |
| Cash flow statement | ||||||||
| Operating cash flow | $84.78M | $167.46M | $92.51M | $54.80M | $122.83M | $67.69M | $174.90M | $106.78M |
| Capital expenditure | $10.95M | $14.99M | $9.06M | $4.63M | $16.24M | $6.43M | $6.90M | $6.78M |
| Free cash flow | $73.83M | $152.47M | $83.44M | $50.17M | $106.59M | $61.26M | $168.00M | $100.00M |
| Investing cash flow | -$29.55M | -$9.79M | -$46.09M | $1.25M | -$21.91M | -$6.43M | $25.89M | -$8.14M |
| Financing cash flow | -$98.16M | -$91.02M | -$99.88M | -$121.83M | -$64.06M | -$60.74M | -$64.87M | -$57.57M |
| Depreciation & amortization | $24.16M | $22.60M | $24.10M | $24.14M | $22.00M | $21.93M | $21.54M | $22.36M |
| Stock-based compensation | $34.41M | $30.96M | $30.71M | $37.21M | $31.05M | $30.73M | $30.66M | $36.07M |
| Dividends paid | $33.66M | $33.98M | $34.34M | $34.34M | $31.59M | $31.63M | $31.83M | $31.55M |
| Share buybacks | $65.00M | $65.00M | $65.00M | $70.00M | $35.00M | $70.00M | $35.00M | $15.00M |
Free plan shows the latest 8 periods; Pro shows all 71 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.